中超控股(002471.SZ):擬向百思利科技增資3484.44萬元 獲其10%股權
格隆匯12月14日丨中超控股(002471.SZ)公佈,公司於2021年12月14日召開第五屆董事會第二十次會議,會議審議通過了《關於對外投資暨簽訂增資協議的議案》,同意公司與江西百思利科技有限公司(“百思利科技”或“標的公司”)及相關股東簽署《增資協議》,擬使用自有資金3484.44萬元向百思利科技進行增資:其中,49.1631萬元計入註冊資本,3435.2769萬元計入資本公積。本次增資完成後,公司將持有目標公司10%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.